Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Hong Kim and Wan Park.
Hong Kim
Connection Strength
2.365
Wan Park
  1. Clinical Prediction Score for Community-Onset Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella Species. J Korean Med Sci. 2019 Apr 15; 34(14):e116.
    View in: PubMed
    Score: 0.205
  2. Effects of Phage Endolysin SAL200 Combined with Antibiotics on Staphylococcus aureus Infection. Antimicrob Agents Chemother. 2018 10; 62(10).
    View in: PubMed
    Score: 0.197
  3. Risk factors for poor outcome in community-onset Clostridium difficile infection. Antimicrob Resist Infect Control. 2018; 7:75.
    View in: PubMed
    Score: 0.193
  4. Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection. Int J Infect Dis. 2018 Jul; 72:8-10.
    View in: PubMed
    Score: 0.192
  5. A Risk-Scoring System for Predicting Methicillin Resistance in Community-Onset Staphylococcus aureus Bacteremia in Korea. Microb Drug Resist. 2018 Jun; 24(5):556-562.
    View in: PubMed
    Score: 0.187
  6. Isolation of Middle East Respiratory Syndrome Coronavirus from a Patient of the 2015 Korean Outbreak. J Korean Med Sci. 2016 Feb; 31(2):315-20.
    View in: PubMed
    Score: 0.163
  7. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea. Emerg Infect Dis. 2015 Dec; 21(12):2186-9.
    View in: PubMed
    Score: 0.162
  8. Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Sci Transl Med. 2021 01 27; 13(578).
    View in: PubMed
    Score: 0.058
  9. Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection. Emerg Infect Dis. 2021 01; 27(1).
    View in: PubMed
    Score: 0.057
  10. Antibody Responses to SARS-CoV-2 at 8 Weeks Postinfection in Asymptomatic Patients. Emerg Infect Dis. 2020 10; 26(10):2484-2487.
    View in: PubMed
    Score: 0.056
  11. Aberrant hyperactivation of cytotoxic T-cell as a potential determinant of COVID-19 severity. Int J Infect Dis. 2020 Aug; 97:313-321.
    View in: PubMed
    Score: 0.055
  12. Prospective evaluation of a rapid antimicrobial susceptibility test (QMAC-dRAST) for selecting optimal targeted antibiotics in positive blood culture. J Antimicrob Chemother. 2019 08 01; 74(8):2255-2260.
    View in: PubMed
    Score: 0.052
  13. Immunogenicity of the Varicella-Zoster Vaccine in Community-Dwelling Non-robust Elderly Individuals Compared to Robust Elderly Individuals: A Prospective Cohort Study. J Gerontol A Biol Sci Med Sci. 2019 07 12; 74(8):1225-1230.
    View in: PubMed
    Score: 0.052
  14. Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine. Infect Chemother. 2018 Dec; 50(4):311-318.
    View in: PubMed
    Score: 0.050
  15. Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics. Eur J Clin Microbiol Infect Dis. 2019 Jan; 38(1):67-74.
    View in: PubMed
    Score: 0.049
  16. Delayed diagnosis of extrapulmonary tuberculosis presenting as fever of unknown origin in an intermediate-burden country. BMC Infect Dis. 2018 Aug 28; 18(1):426.
    View in: PubMed
    Score: 0.049
  17. The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension. Antimicrob Agents Chemother. 2018 07; 62(7).
    View in: PubMed
    Score: 0.048
  18. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. Eur J Clin Microbiol Infect Dis. 2018 Jun; 37(6):1119-1123.
    View in: PubMed
    Score: 0.048
  19. Effect of an intervention targeting inappropriate continued empirical parenteral vancomycin use: a quasi-experimental study in a region of high MRSA prevalence. BMC Infect Dis. 2018 04 16; 18(1):178.
    View in: PubMed
    Score: 0.048
  20. Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea. Korean J Intern Med. 2018 03; 33(2):233-246.
    View in: PubMed
    Score: 0.047
  21. Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies. Ther Drug Monit. 2018 02; 40(1):115-119.
    View in: PubMed
    Score: 0.047
  22. Direct rapid antibiotic susceptibility test (dRAST) for blood culture and its potential usefulness in clinical practice. J Med Microbiol. 2018 Mar; 67(3):325-331.
    View in: PubMed
    Score: 0.047
  23. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015. Emerg Infect Dis. 2017 07; 23(7):1079-1084.
    View in: PubMed
    Score: 0.045
  24. Comparison of Plasma Concentrations of Posaconazole with the Oral Suspension and Tablet in Korean Patients with Hematologic Malignancies. Infect Chemother. 2017 Jun; 49(2):135-139.
    View in: PubMed
    Score: 0.045
  25. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis. Int J STD AIDS. 2017 12; 28(14):1426-1432.
    View in: PubMed
    Score: 0.045
  26. Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea. J Korean Med Sci. 2017 May; 32(5):744-749.
    View in: PubMed
    Score: 0.045
  27. Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection. J Korean Med Sci. 2016 Nov; 31(11):1717-1725.
    View in: PubMed
    Score: 0.043
  28. Viral Load Kinetics of MERS Coronavirus Infection. N Engl J Med. 2016 Sep 29; 375(13):1303-5.
    View in: PubMed
    Score: 0.043
  29. Comparison of serological assays in human Middle East respiratory syndrome (MERS)-coronavirus infection. Euro Surveill. 2015; 20(41).
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.